Showing 1-7 of 7 results for "".
- Skin of Color Society Reports Banner Yearhttps://practicaldermatology.com/news/skin-of-color-society-reports-banner-year/2457824/Kudos to the Skin of Color Society (SOCS) for a banner year. At its recent annual business meeting held in conjunction with the 2018 Annual Meeting of the American Academy of Dermatology, SOCS President Seemal R. Desai, MD, President & Medical Director for Innovative Dermatology, PA, in Plano, Tex…
- Babar Rao, MDhttps://practicaldermatology.com/profiles/babar-rao-md/jJq58P/
- Microneedling Bests Chemical Peels for Fading Acne Scars in Darker Skinhttps://practicaldermatology.com/news/microneedling-bests-chemical-peels-for-fading-acne-scars-in-darker-skin/2461311/Microneedling is significantly more effective then chemical peels for at treating acne scars in patients with darker skin types, a new study shows. For the study, Babar Rao, MD a professor of dermatology and pathology at Robert Wood Johnson Medical School, and researchers randomly assigned 60 pati…
- OMNY Health Launches Integrated Dermatology Data Repository and Research Networkhttps://practicaldermatology.com/news/omny-health-launches-integrated-dermatology-data-repository-and-research-network/2460845/OMNY Health has partnered with community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research. The assembled longitudinal data represents care delivered over the past five years by …
- Nurx Adds Rosacea Care to List of Serviceshttps://practicaldermatology.com/news/nurx-adds-rosacea-care-to-list-of-services/2460832/Nurx, now includes rosacea treatment in its at-home dermatology services. The service consists of a consultation with a Nurx medical provider, a personalized treatment plan for rosacea, home delivery of medication, and ongoing care. The expansion builds on the successful launch of Nurx’s acne and …
- Positive Results Seen in Phase 3 FMX101 Acne Studyhttps://practicaldermatology.com/news/study-positive-results-see-in-phase-3-fmx101-acne-study/2460088/In patients with moderate to severe acne vulgaris, treatment with FMX101 4% topical minocycline foam is well tolerated and effective for reducing the number of inflammatory lesions, according to results of a randomized trial published in the Journal of the American Academy of Dermatology. The stud…
- Personalized Medicine In Action: New Biomarker May Pinpoint Aggressive BCChttps://practicaldermatology.com/news/personalized-medicine-in-action-new-biomarker-may-pinpoint-aggressive-bcc/2458598/A biomarker associated with basal cell carcinoma around the eye may help signal which tumors are likely to be aggressive, report researchers from University of Michigan (U-M) at Ann Arbor. The findings, which appear in JAMA Oncology, may help eliminate some trial and error in matching the right tr…